2017 annual financial data
Revelation Biosciences 2017 Operating margin
Direct answer
Operating margin was 44.17%.
Operating income was 32,687,000 USD and net income was 16,271,000 USD.
Operating cash flow was 24,248,000 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 73,998,000 USD
- Operating income
- 32,687,000 USD
- Net income
- 16,271,000 USD
- Operating cash flow
- 24,248,000 USD